 |
 |
||||
Growing cost of medical care >>
Our latest research >>
press release
DR THOMAS CHEN PRESENTS PKC MAGNETIC BREATHER PUMP AT MEETING OF SOCIETY OF NEURO-ONCOLOCYINGLEWOOD, CALIFORNIA, October 24, 2009 – Pharmaco-Kinesis Corporation (PKC), an advanced medical device company developing smart local drug delivery systems, today reported that Dr. Thomas Chen, a noted neurosurgeon and Chief Oncology Officer of PKC, presented the company’s Magnetic Breather Pump (MBP) at the meeting of the Society of Neuro-Oncology in New Orleans, Louisiana on May 23, 2009.
The presentation included a discussion of current therapies for aggressive brain tumors, a description of the MBP, and the promising results of small animal testing to support MBP development. The abstract of the MBP study received the prestigious Stryker Award in Neuro-Oncology.
The MBP is an implantable pump with a smart catheter that can deliver up to three medications directly to a tumor site or organ, with real time measurement of bioresponse such as VEGF levels, temperature and pressure.
“The MBP can potentially enhance the effectiveness of tumor fighting medications, in the hope of increasing patient survivability from these devastating diseases while also improving a patient’s quality of life,” said Dr. Chen.
The MBP under development by PKC is a potentially revolutionary leap forward in the field of local drug delivery. It is the first implantable pump for the treatment of malignant gliomas and other aggressive cancers of the central nervous system. Also in October 2009 Dr. Chen presented the MBP at the World Federation Neuro-Oncology Conference in Yokohama, Japan.
Under the leadership of Josh Shachar, Co-Founder of PKC and Chief Technology Officer, and Frank Adell, Co-Founder and President of the Company, the PKC R&D team is engaged in several product development programs for commercialization of novel smart local drug delivery technologies and advanced devices to measure biological responses.
For additional information, please contact:
|
